Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
Pre-Tax Income
Modalis Therapeutics Corp
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Modalis Therapeutics Corp
TSE:4883
|
Pre-Tax Income
-¥2.4B
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Pre-Tax Income
¥12.6B
|
CAGR 3-Years
91%
|
CAGR 5-Years
103%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Pre-Tax Income
¥4.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Pre-Tax Income
¥1.4B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-4%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Pre-Tax Income
¥6B
|
CAGR 3-Years
37%
|
CAGR 5-Years
45%
|
CAGR 10-Years
42%
|
|
S
|
StemRIM Inc
TSE:4599
|
Pre-Tax Income
¥170.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Pre-Tax Income?
Pre-Tax Income
-2.4B
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Pre-Tax Income amounts to -2.4B JPY.
What is Modalis Therapeutics Corp's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-62%
Over the last year, the Pre-Tax Income growth was 12%. The average annual Pre-Tax Income growth rates for Modalis Therapeutics Corp have been -76% over the past three years , -62% over the past five years .